Salud Mental

Development of an evidence-based model of rapid testing, counseling and referral patients with HIV, HVC and other STDs in Mexican addiction treatment centers

##plugins.themes.bootstrap3.article.main##

Rodrigo Marín-Navarrete
Carlos Magis-Rodríguez
Luis Villalobos-Gallegos
Adriana Villafuerte-García
Alejandro Pérez-López
Karen Ruiz-Herrera
Ricardo Sánchez-Domínguez
Marisol Ponce-Ramos
Anette Morales-Carcaño
Enrique Bravo-García
Patricia Uribe Zúñiga
María Elena Medina-Mora

Abstract

Introduction. Efforts to identify new cases of HIV, HVC and other STIs, through the application of quick tests, focus on people who inject drugs, without taking into account the fact that the use of alcohol and other drugs of abuse inhibits decision making, increasing the transmission of STIs through risky sexual practices. Accordingly, it is necessary to have detection algorithms that consider people who use multiple drugs to improve the identification of new cases and their subsequent linkage with health services.

Objective. This paper describes the development process of the OPB-APR model for the detection, counseling and referral of people with HIV and other STIs at addiction treatment centers.

Method. The procedure is divided into three phases: 1. A literature review to identify the basic concepts of HIV and other STIs, substance use, risky sexual behaviors, quick tests, and specialized psychological counseling; 2. A feasibility study in which a health professional is trained to implement the OPB-APR model; 3. Drafting of the final version.

Results. The final version of the OPB-APR model was obtained, which describes standardized procedures for detection, counseling and referral to health services.

Discussion and conclusions. The OPB-APR model aims to strengthen the public health system by increasing the coverage of services for the detection of HIV, HCV and other STIs. The above through the implementation of standardized procedures among specialized and non-specialized health professionals of addiction care centers.
Keywords:
HIV, HCV, STIs, addictions, rapid tests, psychological counseling

References

Altice, F. L., Kamarulzaman, A., Soriano, V. V., Schechter, M., & Friedland, G. H. (2010). Treatment of medical, psychiatric, and substance-use comorbidities in people infected with HIV who use drugs. The Lancet, 376(9738), 367-387. doi: 10.1016/S0140-6736(10)60829-X

Benhamou, Y., Bochet, M., Di Martino, V., Charlotte, F., Azria, F., Coutellier, A., ... Poynard, T. (1999). Liver fibrosis progression in human immunodeficiency virus and hepatitis C virus coinfected patients. Hepatology, 30(4), 1054-1058. doi: 10.1002/hep.510300409

Centers for Disease Control and Prevention. (2019). Syphilis Surveillance Supplement 2013–2017. Atlanta, Georgia: U.S. Department of Health and Human Services. Retrieved from: https://www.cdc.gov/std/stats17/syphilis2017/Syphilis-Surveillance-Supplement-2013-2017.pdf

Centro de Investigación en Enfermedades Infecciosas [CIENI]. (2011). 30 años del VIH-SIDA: Perspectivas desde México. Mexico: CIENI. Retrieved from: http://www.censida.salud.gob.mx/descargas/biblioteca/documentos/30aniosdelvihsida.pdf

Centro Nacional para la Prevención y Control del VIH y el sida [CENSIDA]. (2019). Guías y Manuales. Mexico. Retrieved from: https://www.gob.mx/censida/articulos/guias-y-manuales-censida?idiom=es

Chander, G., Himelhoch, S., & Moore, R. D. (2006). Substance abuse and psychiatric disorders in HIV-positive patients. Drugs, 66(6), 769-789. doi: 10.2165/00003495-200666060-00004

Fundación Mexicana para la Salud Hepática. (2011). La hepatitis C como un problema de salud pública en México. Salud Pública de México, 53(Supl 1), S61-S67. ISSN: 0036-3634

Grebely, J., & Tyndall, M. W. (2011). Management of HCV and HIV infections among people who inject drugs. Current Opinion in HIV and AIDS, 6(6), 501-507. doi: 10.1097/COH.0b013e32834bcb36

Johnson, M., Samarina, A., Xi, H., Valdez Ramalho Madruga, J., Hocqueloux, L., Loutfy, M., ... Martinez, M. (2015). Barriers to access to care reported by women living with HIV across 27 countries. AIDS Care, 27(10), 1220-1230. doi: 10.1080/09540121.2015.1046416

Klinkenberg, W. D., Sacks, S., & HIV/AIDS Treatment Adherence, Health Outcomes and Cost Study Group. (2004). Mental disorders and drug abuse in persons living with HIV/AIDS. AIDS Care, 16(Supp1), S22-S42. doi: 10.1080/09540120412331315303

Magis-Rodríguez, C. L., Villafuerte-García, A., Cruz-Flores, R. A., & Uribe-Zuniga, P. (2015). Delayed initiation of antiretroviral therapy in Mexico. Salud Publica de Mexico, 57(Suppl 2), s127-s134. PMID:26545128

Marcus, U., Bremer, V., Hamouda, O., Kramer, M. H., Freiwald, M., Jessen, H., ... Zimmer, Y. (2006). Understanding recent increases in the incidence of sexually transmitted infections in men having sex with men: Changes in risk behavior from risk avoidance to risk reduction. Sexually Transmitted Diseases, 33(1), 11-17. doi: 10.1097/01.olq.0000187224.10428.31

Marín-Navarrete, R., Magis-Rodríguez, C., & Strathdee, S. A. (2017). Sexually transmitted infections and substance use disorders: evidence and challenges in Mexico. Salud Mental, 40(1), 1-4. doi: 10.17711/SM.0185-3325.2017.001

Marín-Navarrete, R., Magis-Rodríguez, C., Medina-Mora, M. E., & Uribe-Zuñiga, P. E. (2019). Guía para la detección, orientación y referencia del VIH y otras ITS en centros para la atención de adicciones. Mexico: INPRFM, CENSIDA.

Marín-Navarrete, R., Medina-Mora, M. E., & Tena-Suck, A. (2014). Breve panorama del tratamiento de las adicciones en México. A. Tena-Suck y R. Marín N. (Eds.). Temas Selectos en Orientación Psicológica VIII: Orientación Psicológica y Adicciones, (1-7).

Marín-Navarrete, R., Medina-Mora, M. E., Pérez-López, A., & Horigian, V. E. (2018). Development and evaluation of addiction treatment programs in Latin America. Current Opinion in Psychiatry, 31(4), 306-314. doi: 10.1097/YCO.0000000000000434

Marín-Navarrete, R., Villalobos-Gallegos, L., Medina-Mora, M. E., & Magis-Rodríguez, C. (2019). Rapid testing and counseling for HIV/STIs in Mexican community-based residential care facilities for substance use disorders: A prospective study protocol. Journal of Substance Use, 24(3), 329-335. doi: 10.1080/14659891.2019.1572801

Moyer, V. A. (2013). Screening for hepatitis C virus infection in adults: US Preventive Services Task Force recommendation statement. Annals of Internal Medicine, 159(5), 349-357. doi: 10.7326/0003-4819-159-5-201309030-00672

Posse, M., Meheus, F., Van Asten, H., Van Der Ven, A., & Baltussen, R. (2008). Barriers to access to antiretroviral treatment in developing countries: a review. Tropical Medicine & International Health, 13(7), 904-913. doi: 10.1111/j.1365-3156.2008.02091.x

Quinn, T. C., Wawer, M. J., Sewankambo, N., Serwadda, D., Li, C., Wabwire-Mangen, F., ... Gray, R. H. (2000). Viral load and heterosexual transmission of human immunodeficiency virus type 1. New England Journal of Medicine, 342(13), 921-929. doi: 10.1056/NEJM200003303421303

Rabkin, J. G., McElhiney, M. C., & Ferrando, S. J. (2004). Mood and substance use disorders in older adults with HIV/AIDS: methodological issues and preliminary evidence. AIDS, 18(Suppl 1), S43-S48. PMID: 15075497

Rawat, A., Uebel, K., Moore, D., Cingl, L., & Yassi, A. (2018). Patient responses on quality of care and satisfaction with staff after integrated HIV care in South African Primary Health Care Clinics. Journal of the Association of Nurses in AIDS Care, 29(5), 698-711. doi: 10.1016/j.jana.2018.04.014

Rhodes, T., Platt, L., Maximova, S., Koshkina, E., Latishevskaya, N., Hickman, M. ... Parry, J. V. (2006). Prevalence of HIV, hepatitis C and syphilis among injecting drug users in Russia: a multi-city study. Addiction, 101(2), 252-266. doi: 10.1111/j.1360-0443.2006.01317.x

Sánchez-Domínguez, R., Villalobos-Gallegos, L., Félix-Romero, V., Morales-Chainé, S., & Marín-Navarrete, R. (2017). Effect of substance use on condom use in the Theory of Planned Behavior: Analysis of differential item functioning. Salud Mental, 40(1), 5-14. doi: 10.17711/SM.0185-3325.2017.002

Scheinmann, R., Hagan, H., Lelutiu-Weinberger, C., Stern, R., Des Jarlais, D. C., Flom, P. L., & Strauss, S. (2007). Non-injection drug use and hepatitis C virus: A systematic review. Drug and Alcohol Dependence, 89(1), 1-12. doi: 10.1016/j.drugalcdep.2006.11.014

Schneider, H., Blaauw, D., Gilson, L., Chabikuli, N., & Goudge, J. (2006). Health systems and access to antiretroviral drugs for HIV in Southern Africa: service delivery and human resources challenges. Reproductive Health Matters, 14(27), 12-23. doi: 10.1016/S0968-8080(06)27232-X

Singh, K. P., Crane, M., Audsley, J., Avihingsanon, A., Sasadeusz, J., & Lewin, S. R. (2017). HIV-hepatitis B virus coinfection: epidemiology, pathogenesis, and treatment. AIDS, 31(15), 2035-2052. doi: 10.1097/QAD.0000000000001574

Strathdee, S. A., Philbin, M. M., Semple, S. J., Pu. M., Orozovich, P., Martinez, G. … Patterson, T. L. (2008). Correlates of injection drug use among female sex workers in two Mexico-U.S. border cities. Drug and Alcohol Dependence, 92(1-3), 132-140. doi: 10.1016/j.drugalcdep.2007.07.001

Sulkowski, M. S., Thomas, D. L., Chaisson, R. E., & Moore, R. D. (2000). Hepatotoxicity associated with antiretroviral therapy in adults infected with human immunodeficiency virus and the role of hepatitis C or B virus infection. JAMA, 283(1), 74-80. doi: 10.1001/jama.283.1.74

Szerman, N., Martínez-Raga, J., Baler, R., Roncero, C., Vega, P., Basurte, I., ... Spinnato, G. (2017). Joint statement on dual disorders: Addiction and other mental disorders. Salud mental, 40(6), 245-247. doi: 10.17711/SM.0185-3325.2017.031

The Joint United Nations Programme on HIV/AIDS [UNAIDS]. (2014). 90-90-90: A transformative agenda to leave no one behind. In: Launch of Vietnam’s 90-90-90 initiative (pp. 2-8).

The Joint United Nations Programme on HIV/AIDS [UNAIDS]. (2016). Do no harm: Health, human rights and people who use drugs. Geneva, Switzerland: Joint United Nations Programme on HIV/AIDS.

Thio, C. L., Seaberg, E. C., Skolasky, R. Jr., Phair, J., Visscher, B., Muñoz, A., & Thomas, D. L. (2002). HIV-1, hepatitis B virus, and risk of liver-related mortality in the Multicenter Cohort Study (MACS). The Lancet, 360(9349), 1921-1926. doi: 10.1016/s0140-6736(02)11913-1

Treloar, C., Newland, J., Rance, J., & Hopwood, M. (2010). Uptake and delivery of hepatitis C treatment in opiate substitution treatment: perceptions of clients and health professionals. Journal of Viral Hepatitis, 17(12), 839-844. doi: 10.1111/j.1365-2893.2009.01250.x

Villalobos-Gallegos, L., Medina-Mora, M. E., Benjet, C., Ruiz-Velasco, S., Magis-Rodriguez, C., & Marín-Navarrete, R. (2019). Multidimensional patterns of sexual risk behavior and psychiatric disorders in men with substance use disorders. Archives of Sexual Behavior, 48(2), 599-607. doi: 10.1007/s10508-018-1227-2

Wong, W., Chaw, J. K., Kent, C. K., & Klausner, J. D. (2005). Risk factors for early syphilis among gay and bisexual men seen in an STD clinic: San Francisco, 2002–2003. Sexually Transmitted Diseases, 32(7), 458-463. doi: 10.1097/01.olq.0000168280.34424.58